Assignee
SENTINEL ONCOLOGY LTD
GB·8 granted patents·8 pending applications·13 citations·filing 2006–2022
Top patents by PatentIndex Score
16 records- 0188US11884656B2Pyrrole derivatives as PLK1 inhibitorsSENTINEL ONCOLOGY LTD·Filed 2021·Granted Jan 30, 2024·1 cites·20 claims
- 0286US10344033B22-aminoquinazoline derivatives as P70S6 kinase inhibitorsSENTINEL ONCOLOGY LTD·Filed 2016·Granted Jul 9, 2019·6 cites·20 claims
- 0384US9630931B2Pharmaceutically active pyrazine derivativesSENTINEL ONCOLOGY LTD·Filed 2012·Granted Apr 25, 2017·3 cites·17 claims
- 0478US11208405B2Pyrrole derivatives as PLK1 inhibitorsSENTINEL ONCOLOGY LTD·Filed 2018·Granted Dec 28, 2021·2 cites·17 claims
- 0576US10973817B2Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2018·Granted Apr 13, 2021·1 cites·25 claims
- 0666US11786524B2Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2021·Granted Oct 17, 2023·0 cites·19 claims
- 0761US10730882B22-aminoquinazoline derivatives as P70S6 kinase inhibitorsSENTINEL ONCOLOGY LTD·Filed 2019·Granted Aug 4, 2020·0 cites·18 claims
- 0854US2008234276A1Heterocyclic Triazines as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 0954US2010048540A1Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 1054US2024287035A1Preparation of a chk1 inhibitor compoundSENTINEL ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1153US2024140908A1A pharmaceutical salt of an arylpyrrole derivativeSENTINEL ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 1253US2024360101A1Pharmaceutical salts of a chk-1 inhibitorSENTINEL ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 1347US2022348565A1Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2020·Application pending·0 cites
- 1446US2017247341A1Pharmaceutically active pyrazine derivativesSENTINEL ONCOLOGY LTD·Filed 2017·Application pending·0 cites
- 1545US2009270416A1N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCERSENTINEL ONCOLOGY LTD·Filed 2007·Application pending·0 cites
- 1642US10144726B2Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancerSENTINEL ONCOLOGY LTD·Filed 2016·Granted Dec 4, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when SENTINEL ONCOLOGY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →